Loading candles…
Q-Line Biotech was incorporated on November 10, 2010. The company operates in the diagnostics and healthcare equipment industries, focusing on developing, manufacturing, and marketing diagnostic reagents, kits, consumables, and point-of-care devices. It also supplies diagnostic and pathology equipment used by healthcare providers. Its business segments include clinical chemistry, haematology, immunodiagnostics, molecular diagnostics, and rapid testing solutions. No information is provided regarding its founders, key management, headquarters, subsidiaries, notable projects, or stock exchange listings.
This page is a live market overview for Q-LINE BIOTECH LIMITED (QLINE) on the NSE. As a listed security, Q-LINE BIOTECH LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for QLINE before placing trades on tick2trade.
As of the latest feed, QLINE last traded at ₹538.7 on NSE, up ₹9.3 (1.76%) from the previous close of ₹529.4. Today's session range is ₹527.6 – ₹542.15, against a 52-week band of ₹431 – ₹600. Traded volume today stands at 34.40K shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for QLINE in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether QLINE is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for Q-LINE BIOTECH LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in QLINE. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated QLINE option chain page linked from this overview.
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.